| |
|
|
Drug name
|
Condition |
Division |
| Fabrazyme® (agalsidase beta) |
Fabry Disease |
Accredo Therapeutics |
| FEIBA® VH (anti-inhibitor coagulant complex) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| Flebogamma® (immune globulin intravenous [human]) |
Immune Deficiency |
Accredo Therapeutics |
| Flolan® (epoprostenol sodium) |
Pulmonary Hypertension |
Accredo Therapeutics |
| Follistim® AQ (follitropin beta, recomb) |
Infertility |
Accredo Nova Factor |
| Forteo® (teriparatide [rDNA origin]) |
Osteoporosis |
Accredo Nova Factor |
| Fragmin® (dalteparin sodium) |
DVT/Anticoagulation |
Accredo Nova Factor |
| Fuzeon® (enfuvirtide) |
HIV |
Accredo Therapeutics |